Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024

Yahoo FinanceJul 18 16:05 ET

Crinetics Pharmaceuticals Insider Sold Shares Worth $1,485,000, According to a Recent SEC Filing

Jeff E. Knight, Chief Operating Officer, on July 15, 2024, sold 27,000 shares in Crinetics Pharmaceuticals (CRNX) for $1,485,000. Following the Form 4 filing with the SEC, Knight has control over a

MT NewswiresJul 17 17:46 ET

Piper Sandler Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $97

Piper Sandler analyst Yasmeen Rahimi maintains $Crinetics(CRNX.US)$ with a buy rating, and maintains the target price at $97.According to TipRanks data, the analyst has a success rate of 38.9% and a

Moomoo NewsJul 17 12:31 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Elevance Health (ELV) and Johnson & Johnson (JNJ)

TipRanksJul 17 11:51 ET

XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?QuantumScape Corporation (NYSE:QS) stock jumped 64.34% after the company announced it entered into an

BenzingaJul 14 13:22 ET

Insider Sale: Chief Scientific Officer Stephen Betz Sells Shares of Crinetics Pharmaceuticals ...

Yahoo FinanceJul 12 19:01 ET